Turning the tables on the US that has been criticising India for lax intellectual property rules, New Delhi has asked Washington to tighten its own laws to discourage increasing practices of ‘ever greening’ and ‘trolling’ by US drug companies which lead to wrongful profiteering and patent extension.
Commerce and Industry Minister Anand Sharma, during his recent visit to the US, took up the issue of patents misuse by US companies in his meetings with US Trade Representative Michael Froman and US Commerce Secretary Penny Pritzker.
Trolling is a process through which an individual or a company buys a patent, often from a bankrupt company, and threatens to sue other companies manufacturing a product similar to the patented one without itself manufacturing the product.
Ever-greening, on the other hand, is a process through which patent holders try to extend patents beyond its normal life by making minor changes in the product.
To Read the Complete Story Click Here